Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center

被引:18
|
作者
Chen, Yike [1 ]
Xu, Xiaohui [2 ]
Cao, Jing [3 ]
Jie, Yuanqing [4 ]
Wang, Linkai [1 ]
Cai, Feng [1 ]
Chen, Sheng [1 ]
Yan, Wei [1 ]
Hong, Yuan [1 ]
Zhang, Jianmin [1 ]
Wu, Qun [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 4, Sch Med, Department Neurosurg, Yiwu, Peoples R China
[3] Univ South, Affiliated Changsha Cent Hosp, Hengyang Med Sch, Dept Stat Off, Changsha, Peoples R China
[4] Affiliated Quzhou Peoples Hosp Wenzhou Med Univ, Dept Neurosurg, Quzhou, Peoples R China
来源
关键词
giant pituitary adenoma; transsphenoidal surgery; CSF leak; Knosp grade; extent of resection; CAVERNOUS CAROTID-ARTERY; ENDOSCOPIC ENDONASAL; DIABETES-INSIPIDUS; FALSE ANEURYSM; CLINICOPATHOLOGICAL CLASSIFICATION; INSTITUTIONAL EXPERIENCE; MICROSURGICAL TREATMENT; SURGICAL-TREATMENT; PREDICTORS; MANAGEMENT;
D O I
10.3389/fendo.2022.879702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundTranssphenoidal surgery (TSS) is first-line treatment for giant pituitary adenomas (PAs). Although PA is a benign neuroendocrine tumor that originates from adenohypophysial cells, the surgical outcomes and prognosis of giant PAs differ significantly due to multiple factors such as tumor morphology, invasion site, pathological characteristics and so on. The aim of this study was to evaluate surgical outcomes of giant PAs in a single-center cohort. MethodsThe clinical features and outcomes of 239 patients with giant PA who underwent sphenoidal surgery at the Second Affiliated Hospital of Zhejiang University School of Medicine from January 2015 to October 2021 were collected from medical records. The basic clinical information (age, gender, function etc.), surgical procedure, imaging features (maximum diameter, invasion characteristics, tumor shape etc.) and histopathological characteristics (pathological results, Ki-67, P53 etc.) were retrospectively reviewed. SPSS 25.0 and Stata 12.0 software were used for statistical analysis. ResultsA total of 239 patients with giant PAs underwent TSS, of which 168 surgeries (70.29%) were endoscopic endonasal transsphenoidal (EETS) and 71 (29.71%) were microscopic transsphenoidal (MTS). The mean preoperative maximum diameter in the cohort was 45.64 mm. Gross-total resection was achieved in 46 patients (19.25%), near-total in 56 (23.43%), subtotal in 68 (28.45%), and partial in 69 (28.87%) patients. The maximum tumor diameter and Knosp grade were the significant factors that limited the extent of the resection of giant PAs. A total of 193 patients (80.75%) experienced surgical complications, and the most common complications were postoperative diabetes insipidus (DI) (91, 38.08%), intracranial infection (36, 15.06%) and cerebrospinal fluid (CSF) leaks (37, 15.48%). In addition, there was a significant difference in the incidence of CSF leaks between the neuroendoscopy group and the microscopic group (P < 0.05). ConclusionThe management of giant PAs remains a therapeutic challenge due to their large size and postoperative complications. The maximum diameter and Knosp grade of giant PAs significantly limited the extent of resection, which warrants a reasonable surgical plan.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Simultaneous Transsphenoidal and Transventricular Endoscopic Approaches for Giant Pituitary Adenoma With Hydrocephalus
    Koktekir, Ender
    Karabagli, Hakan
    Ozturk, Kayhan
    JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (01) : E39 - E42
  • [42] Remission, complications, and overall survival in transsphenoidal pituitary surgery—a Swedish single-center experience of 578 patients
    Ola Fridman Bengtsson
    Ola Sunnergren
    Ivan Segerhammar
    Petter Förander
    Martin Olsson
    Anna-Lena Hulting
    Pär Stjärne
    Acta Neurochirurgica, 2023, 165 : 685 - 692
  • [43] Delayed Hyponatremia Following Transsphenoidal Surgery for Pituitary Adenoma Commentary
    Fahlbusch, Rudolf
    NEUROLOGIA MEDICO-CHIRURGICA, 2008, 48 (11) : 492 - 493
  • [44] Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma
    Benveniste, RJ
    King, WA
    Walsh, J
    Lee, JS
    Delman, BN
    Post, KD
    JOURNAL OF NEUROSURGERY, 2005, 102 (06) : 1004 - 1012
  • [45] Pneumocephalus as a Complication of Transsphenoidal Surgery for Pituitary Adenoma: A Case Report
    Attaya, Eman N.
    Lado-Abeal, Joaquin
    Rivas, Ana M.
    CUREUS, 2018, 10 (08):
  • [46] Transsphenoidal surgery for pituitary adenomas: early results from a single center (vol 17, pg 551, 2019)
    Karamouzis, I.
    Caputo, M.
    Mele, C.
    Nuzzo, A.
    Zavattaro, M.
    Car, P.
    Panzarasa, G.
    Prodam, F.
    Marzullo, P.
    Aimaretti, Gianluca
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 18 (01): : 115 - 115
  • [47] Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma
    Ajlan, Abdulrazag M.
    Bin Abdulqader, Sarah
    Achrol, Achal S.
    Aljamaan, Yousef
    Feroze, Abdullah H.
    Katznelson, Laurence
    Harsh, Griffith R.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2018, 79 (02) : 117 - 122
  • [48] Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma
    Berkmann, Sven
    Schlaffer, Sven
    Buchfelder, Michael
    JOURNAL OF NEUROSURGERY, 2013, 119 (06) : 1447 - 1452
  • [49] Postoperative Cerebral Vasospasm Following Transsphenoidal Pituitary Adenoma Surgery
    Eseonu, Chikezie I.
    ReFaey, Karim
    Geocadin, Romergryko G.
    Quinones-Hinojosa, Alfredo
    WORLD NEUROSURGERY, 2016, 92 : 7 - 14
  • [50] Use of Neuronavigation and Augmented Reality in Transsphenoidal Pituitary Adenoma Surgery
    Bopp, Miriam H. A.
    Sass, Benjamin
    Pojskic, Mirza
    Corr, Felix
    Grimm, Dustin
    Kemmling, Andre
    Nimsky, Christopher
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)